Article
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience - 15 Oct 2003
Ferrante Robert J, Kubilus James K, Lee Junghee, Ryu Hoon, Beesen Ayshe, Zucker Birgit, Smith Karen, Kowall Neil W, Ratan Rajiv R, Luthi-Carter Ruth, Hersch Steven M
Abstract excerpt
The precise cause of neuronal death in Huntington's disease (HD) is unknown. Although no single specific protein-protein interaction of mutant huntingtin has emerged as the pathologic trigger, transcriptional dysfunction may contribute to the neurodegeneration observed in HD. Pharmacological treatment using the histone deacetylase inhibitor sodium butyrate to modulate transcription significantly extended survival...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
